Roc vs. Sux - The CURASMUR Trial

February 18, 2020 00:19:11
Roc vs. Sux - The CURASMUR Trial
Critical Care Perspectives in Emergency Medicine
Roc vs. Sux - The CURASMUR Trial

Feb 18 2020 | 00:19:11

/

Show Notes

The debate on the ideal neuromuscular blocking agent for RSI in emergency intubations rages on. In this podcast, we review the latest randomized trial comparing rocuronium with succinylcholine in out-of-hospital patients needing emergency tracheal intubation – The CURASMUR Trial. Emergency medicine airway guru Dr. Ken Butler takes us through the paper and provides his expert opinion on which NMBA you should be reaching for in your next intubation!

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

May 19, 2022 00:22:48
Episode Cover

Refractory OHCA - Does ECPR and Early Angiography Improve Outcome?

In a recent podcast we reviewed the ARREST Trial, which demonstrated significant improvement in survival among OHCA patients at a single center randomized to...

Listen

Episode 0

October 26, 2021 00:26:40
Episode Cover

Vasopressin and Steroids for IHCA?

In 2009 and 2013 investigators published studies that demonstrated improved outcomes in patients with IHCA who received vasopressin and steroids in addition to epinephrine. ...

Listen

Episode 0

December 13, 2022 00:24:33
Episode Cover

Double Sequential External Defibrillation for Refractory Ventricular Fibrillation

More than 350,000 cardiac arrests occur each year in North America.  Approximately 100,000 of these arrests are due to shockable rhythms.  Unfortunately, many patients...

Listen